E. coli Infection and Pathogenesis

Questions and Answers

Enterotoxigenic E. coli (ETEC)

Abdominal cramps

Fever

Hemolytic uremic syndrome (correct)

Dehydration (correct)

False

Through contaminated infant formula and weaning food. Signup and view all the answers

Verotoxin (VT) Signup and view all the answers

Feco-oral through contaminated food. Signup and view all the answers

anorexia, vomiting, and abdominal cramps Signup and view all the answers

Enterohemorrhagic E. coli (EHEC) Signup and view all the answers

Study Notes

Different strains of E.coli exhibit distinct virulence factors that contribute to various forms of diarrhea.
Understanding pathogenesis is crucial for recognizing symptoms and complications associated with E.coli infections.
E.coli infections can lead to severe complications, including hemolytic uremic syndrome.

Major cause of traveler's diarrhea; ranked second after rotavirus in hospital-based gastroenteritis cases.
Transmission occurs primarily through fecal-oral contact, contaminated food, and occasionally through water.
High infecting dose required (10^9 to 10^10 bacteria).
Pathogenesis involves colonization of the proximal small intestine using fimbriae, secreting heat-labile (LT) and heat-stable (ST) toxins.
LT affects enterocytes by increasing cyclic AMP, leading to excessive fluid secretion and diarrhea; ST activates guanylate cyclase for similar effects.
Symptoms include rapid onset diarrhea (1-2 days), anorexia, vomiting, and abdominal cramps; lasts 1-5 days in well-nourished and can extend to 3 weeks in malnourished individuals.
Diagnosis via stool culture and pathogenicity gene detection; treatment includes fluid replacement and antibiotics like ciprofloxacin.

Causes inflammatory diarrhea by invading colonic enterocytes; resembles Shigella in characteristics.
Transmission mainly through fecal-oral route from infected individuals.
Pathogenesis involves colon invasion and proliferation within the cells, causing cell death.
Characterized by polymorphonuclear leukocyte infiltration distinct in clinical presentations.
Symptoms present swiftly (10-18 hours IP), including fever and dysentery.
Diagnosis via stool culture and gene detection; treated with co-trimoxazole and erythromycin.

Significant cause of diarrhea in infants, notably in developing countries.
Transmission predominantly through contaminated infant formula or weaning food.
Pathogenesis involves adherence to intestinal mucosa, leading to the loss of microvilli and subsequent non-inflammatory osmotic diarrhea.
Symptoms include vomiting, fever, and glucogenic diarrhea that can lead to dehydration.
Diagnosis through stool cultures and detection of attaching and effacing genes; treatment focuses on rehydration and nutritional support.

Associated with severe conditions like hemorrhagic colitis and hemolytic uremic syndrome; notably caused by serotype O157.
Reservoirs include cattle and humans, with foodborne transmission common.
Produces attaching and effacing lesions; secretes Vero toxins (VT-1 and VT-2) that halt protein synthesis, leading to intestinal damage.
Clinical presentation includes abdominal cramps, diarrhea with blood, and potential systemic issues like acute renal failure.
Diagnosis via VT detection or anti-VT antibodies; dehydration treatment is critical while antibiotics do not play a beneficial role.

Recently identified strain primarily linked to acute and persistent diarrhea.
Displays a longer incubation period of 20-48 hours compared to other strains, emphasizing the need for awareness in symptom management.